Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
PROTEOSTASIS THERAPEUTICS (PTI)
Last proteostasis therapeutics earnings: 3/10 04:36 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.proteostasis.com/investor-overview
Company Research
Source: GlobeNewswire
14-day Study of PTI-801, Company’s Third Generation Corrector, in CF Patients on Background Orkambi® Enrolling Ahead of Schedule; Results from All Three Cohorts Expected Q2'18 Company Announces Additional Study of PTI-428 in CF Subjects on Symdeko™ to Support Path to NDA, with Initial Data Anticipated in Early 2019 Triple Combination CF Study of PTI-428 + PTI-801 + PTI-808 on Track to Initiate in Q2’18; Preliminary Results Anticipated in 2H’18 Initial Data from PTI’s Double Combination Study of PTI-801 and PTI-808 in CF Patients Expected Mid 2018 CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced financial results for the fourth quarter and year ended December 31, 2017 and provided a business update.
Show less
Read more
Impact Snapshot
Event Time:
PTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PTI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PTI alerts
High impacting PROTEOSTASIS THERAPEUTICS news events
Weekly update
A roundup of the hottest topics